Drug coverage status influenced the treatments that were selected for Medicare beneficiaries with myeloma and, consequently, their overall survival.
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2MothFN
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2MothFN